Master coronary artery calcium scoring CT with Agatston methodology, prospective ECG gating, standardised slice thickness, DRL benchmarks, and 10 critical pitfalls for radiographers and radiologists.

7 Expert Steps to Master Coronary Artery Calcium Scoring CT: Agatston Protocol, Gating, and Pitfall Framework

📅 18 June 2026 ⏱ 42-minute read 🗂 Cardiovascular Imaging | CT Protocols ✅ Medically Reviewed

⚡ At a Glance — Protocol Snapshot

kVp

120

Pitch

0.2 (Gated)

150 (Fixed)

Rotation time

0.33 s

Contrast

None

Trigger

Prospective ECG

Slice thickness

3.0 mm (fixed)

HU threshold

≥130 HU

Min. lesion area

≥1 mm²

Agatston score

Weighted sum

⚠ Primary scanning pitfall: Performing the scan with a slice thickness other than the standardised 3.0 mm directly skews the calculated Agatston volumetric score, rendering the result non-comparable with reference cohorts and making risk-category reclassification highly likely.

1. Introduction — why coronary artery calcium scoring CT changes cardiovascular risk management

Coronary artery calcium scoring CT (CACS CT) is arguably the most cost-efficient non-invasive cardiovascular imaging test available to the modern radiography department. Requiring no intravenous contrast, no pharmacological stress agent, and achieving a sub-millisievert effective dose on contemporary wide-detector equipment, the coronary artery calcium scoring CT examination delivers a single, reproducible numerical output — the Agatston score — that independently predicts major adverse cardiovascular events (MACE) with a predictive power that exceeds traditional risk factor modelling alone.^[1] Its clinical impact extends from asymptomatic risk stratification through to the reclassification of intermediate-risk patients, the guidance of statin prescribing decisions, and the exclusion of obstructive coronary disease in appropriately selected populations.

Despite its apparent simplicity — a brief, non-contrast, gated cardiac CT — the protocol is remarkably sensitive to technical error. A deviation as small as changing the reconstruction slice thickness from 3.0 mm to 2.5 mm can produce Agatston scores that differ by 20–40%, shifting patients between risk categories without any change in their underlying disease burden.^[2] Similarly, inappropriate gating, ROI misplacement, and boundary-attribution errors related to extra-coronary calcification represent genuine threats to diagnostic accuracy. For radiographers and radiologists working in busy cardiovascular imaging units, understanding and controlling every variable of the calcium scoring protocol is not academic pedantry — it is fundamental to the validity of the report delivered to the referring cardiologist.

This article provides a complete, evidence-based protocol reference for coronary artery calcium scoring CT: from scanner configuration and ECG-gating strategy through Agatston methodology, dual-energy and photon-counting adaptations, radiation dose optimisation, the full spectrum of detectable pathologies, and a comprehensive three-audience pitfall framework covering radiographers, radiologists, and non-radiology physicians.

🫀 Clinical Context

Coronary artery disease (CAD) remains the leading cause of death globally, responsible for an estimated 9.4 million deaths annually as of 2025.^[3] Approximately 50% of individuals who die suddenly from a first myocardial infarction have no prior known symptoms. Coronary artery calcium scoring CT provides an actionable, objective measure of subclinical atherosclerotic burden in asymptomatic individuals, enabling preventive intervention years before an acute coronary event occurs. Current guidelines from the ACC/AHA designate CACS as a Class IIa recommendation for intermediate-risk adults (10-year PCE risk 7.5–20%) when additional risk stratification would alter management decisions.^[4]

2. Cardiac anatomy and HU values relevant to calcium scoring

The coronary arteries arise from the aortic root immediately above the aortic valve cusps. The left main coronary artery (LMCA) bifurcates into the left anterior descending (LAD) artery — the most commonly and heavily calcified vessel — and the left circumflex (LCx) artery. The right coronary artery (RCA) originates from the right coronary sinus and travels in the right atrioventricular groove. Together, these three major vessels — LAD, LCx, and RCA — form the basis of per-vessel Agatston scoring. In some individuals, a large ramus intermedius arises at the left main bifurcation and is scored separately.

For Agatston methodology to function accurately, the CT acquisition must be able to reliably distinguish coronary calcium from adjacent soft tissue structures. The table below summarises the key HU reference values encountered on a non-contrast cardiac CT scan and their clinical significance.

Structure / Tissue	HU Range	Significance for CACS
Air (lung parenchyma)	−1000 HU	Defines field edges; key for scan coverage confirmation
Epicardial fat	−50 to −100 HU	Surrounds coronary arteries; important for vessel localisation
Myocardium	45–65 HU	Reference soft tissue; does not trigger calcium threshold
Blood pool (un-opacified)	35–55 HU	Chamber lumen; remains below 130 HU threshold
Pericardium	10–30 HU	Thin membrane; pericardial calcification causes attribution pitfall
Aortic wall / intima	40–60 HU	Ascending aortic atheroma can be erroneously included in score
Coronary calcium threshold	≥130 HU	Agatston criterion — any voxel at or above this density within an area ≥1 mm² is scored
Dense coronary calcium	200–400 HU	Density weighting factor 2–3; contributes significantly to total score
Very dense calcification	>400 HU	Density weighting factor 4 — maximum contribution per lesion
Mitral annular calcification	300–1000+ HU	Extra-coronary; primary boundary-attribution pitfall for radiologists
Pericardial calcification	200–900 HU	Must be excluded — misattribution inflates score falsely
Aortic valve calcium	400–1500 HU	Clinically significant independently; not included in Agatston coronary score

Agatston density weighting factor (DWF) methodology

The Agatston score for each individual coronary lesion is calculated by multiplying the lesion area (in mm²) by a density weighting factor (DWF) determined by the peak HU attenuation within that lesion. The DWF values are standardised as follows: lesions measuring 130–199 HU receive a DWF of 1; 200–299 HU receive a DWF of 2; 300–399 HU receive a DWF of 3; and lesions at ≥400 HU receive the maximum DWF of 4.^[5] Per-lesion scores are summed across each vessel, and vessel totals are summed to produce the total Agatston score. Volume scoring and mass scoring represent complementary metrics with reduced inter-scan variability, but the Agatston score remains the universally reported and guideline-endorsed standard.

Relevant cardiac anatomy by region

Proximal LAD and LMCA junction

The LAD accounts for approximately 50–60% of total coronary calcium burden in most study populations, reflecting its susceptibility to turbulent flow and haemodynamic stress at its proximal segment.^[6] On axial CACS images, the proximal LAD appears immediately anterior to the right ventricular outflow tract, embedded within the epicardial fat in the anterior interventricular groove. Calcium at the LMCA must be carefully differentiated from ostial LAD or LCx calcium on axial and multiplanar reconstruction (MPR) views.

Right coronary artery (RCA)

The RCA contributes approximately 25–30% of total coronary calcium in most patient series. It travels in the right atrioventricular groove and is readily identified on axial slices. A key radiographer consideration is that the RCA is more susceptible to cardiac motion artefact than the LAD due to its smaller calibre and greater transverse displacement during systole, reinforcing the importance of strict heart rate control and optimal gating window placement.

Left circumflex artery (LCx)

The LCx is the vessel most frequently affected by partial volume averaging errors when close to the mitral annulus, which is a critical pitfall site. Calcification within the LCx territory — particularly at obtuse marginal branch origins — must be differentiated from the adjacent mitral annular calcification that commonly occurs in the same spatial region.

Extra-coronary calcium deposits

Several non-coronary structures produce high-attenuation deposits visible on CACS acquisitions. Aortic valve calcification (AVC) is a separately reported finding of independent clinical significance, associated with aortic stenosis development. Mitral annular calcification (MAC) is a degenerative process commonly encountered in elderly patients, particularly women, and represents the most frequent source of score inflation through boundary misattribution. Pericardial calcification, though less common, can appear ring-like and is associated with constrictive pericarditis. Ascending aortic atheroma is excluded from coronary scores but should be reported separately.

🫀

Standardise your cardiac CT workflow across every scanner

SATMED Health protocol management tools help cardiac imaging teams maintain consistent Agatston methodology, ECG gating parameters, and DRL compliance across multi-site networks.

Explore Cardiac CT Solutions →

3. Scanning technique — 7 expert steps for coronary artery calcium scoring CT

The technical precision required for CACS CT exceeds that of most routine chest examinations because every parameter choice directly influences the Agatston number produced. Small deviations in slice thickness, gating window, reconstruction kernel, or field of view alter the scored calcium burden without altering the patient’s true atherosclerotic load. The seven steps below integrate ACC/AHA and SCCT guidelines with current best practice for 64-slice and above scanners.^[7]

Patient preparation and heart rate optimisation

Instruct the patient to avoid caffeine and smoking for four hours before scanning, as both elevate heart rate and increase cardiac motion blurring. Obtain a 12-lead ECG or preliminary monitoring trace to confirm baseline rhythm. For prospective axial gating (the standard acquisition mode), a heart rate of <65 bpm is strongly preferred; some high-temporal-resolution dual-source platforms permit reliable acquisition up to 75–80 bpm. If the rate exceeds 65 bpm, consider low-dose oral beta-blockade (25–50 mg metoprolol) 60 minutes before the scan, subject to contraindication screening (asthma, AV block, severe heart failure, bradycardia).^[8] Beta-blockade is less critical for CACS than for CCTA because spatial resolution requirements for calcium detection are lower, but rate control still reduces motion artefact that can corrupt lesion boundaries at the DWF threshold.
Patient positioning and ECG lead placement

Position the patient supine, arms raised above the head (superman position) to reduce beam-hardening artefact from arm soft tissue in the scan field. Apply the four-lead ECG monitoring electrodes in a standard configuration: RA lead on the right shoulder (below clavicle), LA on the left shoulder, RL on the lower right abdomen, and LL on the lower left abdomen. Verify a clean R-wave trace on the scanner console before proceeding. Positioning the ECG lead cables away from the scan plane minimises streak artefacts from lead connectors, which are occasionally misidentified as dense calcifications on uncritical review.
Localiser and scan range definition

Acquire a low-dose PA and lateral scout (topogram) for coverage planning. Define the scan range from 1 cm above the tracheal carina to 1 cm below the cardiac apex. This standard cardiac chest coverage encompasses all major epicardial coronary artery territories without unnecessary chest irradiation. The scan is acquired in a craniocaudal (head-to-foot) direction. Crucially, the field of view (FOV) should be set to encompass the entire cardiac silhouette (typically 200–260 mm), not the full thoracic diameter — oversizing the FOV degrades spatial resolution and unnecessarily increases the reconstructed voxel size relative to the 3.0 mm slice standard.
ECG gating mode — prospective axial triggering

Coronary artery calcium scoring CT universally employs prospective ECG-triggered axial acquisition (step-and-shoot mode). The scanner delivers radiation only during the quiescent diastolic phase of the cardiac cycle, typically at 70–80% of the R–R interval, where cardiac motion is minimal. This approach reduces effective dose by 60–80% compared to retrospective helical gating, which is the principal reason why CACS is achievable at sub-millisievert doses. Retrospective gating is appropriate for CCTA (Day 11) where multi-phase reconstruction is required, but it is not indicated for calcium scoring. Dual-source CT platforms can use a single-heartbeat prospective wide-band acquisition for accurate scoring regardless of heart rate, offering particular advantage in patients unable to lower their rate adequately.^[9]
Acquisition parameters — the non-negotiables

Set kVp to 120 (standardised; do not reduce to 100 kV as this alters HU calibration relative to the 130 HU threshold). Set mA to 150 (fixed) — automatic mA modulation is avoided because Agatston score reproducibility depends on consistent noise levels. Set rotation time to 0.33 s or the shortest available for motion blur reduction. Reconstruct with a slice thickness of exactly 3.0 mm at a 3.0 mm interval — this is the single most critical parameter for Agatston comparability. Reconstruct using a medium-smooth cardiac kernel (equivalent to Siemens B25f, GE Standard, Philips B, Canon FC01): a sharp bone kernel overestimates calcium density; a very soft kernel underestimates lesion boundaries.
Reconstruction and post-processing

Beyond the 3.0 mm acquisition dataset, reconstruct an additional 0.5–1.0 mm thin-slice axial series using a medium-sharp cardiac kernel for anatomical review and extra-coronary calcification attribution. This thin-slice dataset is not used for Agatston scoring (as only the 3.0 mm series is validated against MESA and other reference cohorts) but is invaluable for distinguishing mitral annular calcification from LCx disease. Apply deep learning image reconstruction (DLR) where available (GE TrueFidelity, Siemens ADMIRE, Canon AiCE) to the thin-slice review series to reduce image noise without altering 3.0 mm Agatston accuracy. Transfer the 3.0 mm dataset to validated calcium scoring software (Syngo.via, Vitrea, Intellispace) that applies the DWF algorithm automatically with manual lesion verification.
Breath-hold and quality confirmation

Train the patient in breath-hold technique before scanning: full inspiration, then suspend breathing. The CACS acquisition typically requires a single breath-hold of 10–15 seconds. The prospective step-and-shoot mode acquires data only during the ECG-gated quiescent window within each heartbeat, so the actual cardiac X-ray exposure time per cycle is brief (<200 ms), but consistent breath suspension prevents diaphragm motion that can shift the cardiac position between axial steps. Following acquisition, review the raw images for: (a) cardiac motion artefact at coronary margins, (b) respiratory step artefacts between axial slabs, and (c) ECG triggering irregularities. Rescan only if motion or step artefacts directly overlie calcified lesions identified on initial review — unnecessary repeat scanning doubles patient dose.

Scanner generation comparison table

Scanner type	Gating mode	Effective dose (mSv)	HR limit (bpm)	Key advantage
16-slice MDCT	Prospective axial	1.5–3.0	<65	Widely available; adequate for CACS
64-slice MDCT	Prospective axial	1.0–2.0	<65	ACC/AHA reference platform for MESA-equivalent scoring
128-slice dual-source	Prospective axial / single beat	0.8–1.5	<80	Extended HR tolerance; ~80% dose reduction vs. retrospective
256/320-slice wide detector	Single-beat axial coverage	0.6–1.2	<90	Entire heart in one rotation; eliminates step artefact
Photon-counting CT (PCCT)	Prospective axial + spectral	0.3–0.8	<90	50% dose reduction possible; monoE threshold adaptation required

Dual-energy CT and photon-counting adaptations for calcium scoring

Technique	Acquisition modification	Agatston threshold adaptation	Clinical benefit
Dual-energy CT (DECT)	Mixed virtual monoenergetic images at 70 keV equivalent	130 HU standard threshold maintained	Simultaneous coronary stenosis estimation without additional scan
Photon-counting CT (PCCT)	Low mono-energetic reconstructions (60–100 keV)	Modified thresholds validated at each keV level; 70 keV = 130 HU equivalent^[10]	50% dose reduction with maintained score accuracy for medium/high-density calcium
DLR + PCCT combined	Noise reduction permits lower dose acquisition	Standard 130 HU if 70 keV monoE images used	Sub-0.5 mSv effective dose feasible in slim patients; emerging evidence only

Deep learning reconstruction (DLR) considerations in CACS

DLR algorithms trained on conventional filtered back-projection (FBP) data produce excellent noise reduction on the thin-slice review series. However, their effect on the 3.0 mm Agatston dataset requires site-specific validation. Early evidence suggests that DLR at low noise-reduction settings preserves Agatston scores within ±10% of FBP reference values, but aggressive DLR denoising can smooth lesion boundaries and reduce the peak HU within a given lesion, potentially downgrading the DWF applied.^[11] Until scanner-specific validation datasets are published for each DLR version, apply DLR only to the thin-slice review dataset and use iterative reconstruction or FBP for the 3.0 mm Agatston series.

4. Contrast media protocol — why coronary artery calcium scoring CT is always non-contrast

Coronary artery calcium scoring CT is, by definition and by regulatory requirement, a non-contrast examination. The administration of intravenous iodinated contrast media is not only unnecessary but would fundamentally invalidate the examination by elevating the HU values within the coronary lumen and adjacent cardiac structures above the 130 HU threshold, creating spurious high-attenuation areas that would be falsely scored as coronary calcium. A contrast-enhanced study cannot substitute for a dedicated non-contrast CACS acquisition under any clinical circumstance.

ℹ Protocol Rationale

The Agatston score is calibrated against reference normative data (MESA, HNR, Rotterdam Study) derived exclusively from non-contrast acquisitions at 120 kVp with 3.0 mm slice thickness. Any deviation from this technical framework — including contrast administration, kVp reduction, or slice thickness change — renders the score non-comparable with those reference cohorts and therefore clinically unreliable for risk percentile assignment.

Safety checklist for the non-contrast CACS examination

While no contrast is administered, a pre-examination safety checklist remains essential to ensure the examination is performed within appropriate clinical indications and that the scan is technically adequate:

Check	Detail	Action if failed
Indication confirmed	Intermediate-risk asymptomatic patient, 10-yr PCE risk 7.5–20%, or border zone with clinical uncertainty	Clarify with referring physician; symptomatic patients require CCTA not CACS
Prior cardiac surgery / stenting	Post-CABG patients may have surgical clips causing artefact; stented patients derive limited extra value from CACS	Discuss with reporting radiologist before proceeding
Pregnancy	Absolute contraindication to elective cardiac CT	Defer examination; document discussion
Pacemaker / CIED	Causes metal artefact; does not contraindicate CT but may degrade image quality in RV/RCA territory	Document device type; proceed with awareness of artefact zone
Heart rate <65 bpm	Required for standard prospective gating quality	Consider beta-blockade; reschedule if acute tachycardia due to anxiety
Ability to breath-hold 10–15 s	Essential for motion-free acquisition	Train patient; for inability, consider wide-detector single-beat acquisition
BMI / patient size	High BMI (>35 kg/m²) increases image noise at fixed 150 mA; may require mA adjustment	Increase mA to maintain adequate CNR for calcium detection; document dose deviation

💉

Eliminate protocol variability across your cardiology suite

SATMED Health injection and contrast management systems ensure that every cardiac CT examination is delivered with the technical precision cardiovascular risk scoring demands.

View Cardiac CT Tools →

5. Radiation dose — DRL benchmarks and five strategies for dose optimisation

Coronary artery calcium scoring CT is among the most dose-efficient cardiac CT examinations available. The fundamental use of prospective ECG-triggered axial acquisition means that X-ray exposure is delivered only during the brief diastolic quiescent window of each cardiac cycle, eliminating the substantial overrange radiation inherent in retrospective helical CCTA. On contemporary 128-slice and wider-detector platforms, CACS effective doses routinely fall below 1.0 mSv, with photon-counting CT platforms demonstrating feasibility below 0.5 mSv.^[12]

Metric	EC RP 185 / European DRL	AAPM / ACR Benchmark	ICRP Reference	Modern Best Practice
CTDIvol	7.0 mGy	6.0 mGy	—	3.0–5.0 mGy (prospective axial)
DLP	100 mGy·cm	90 mGy·cm	—	50–80 mGy·cm
Effective dose	1.4 mSv	1.0–2.0 mSv	1.0 mSv (guidance)	0.6–1.2 mSv (64-slice); <0.5 mSv (PCCT)
SSDE	—	Size-adjusted ±20%	—	Apply for patients >100 cm effective diameter
DRL = Diagnostic Reference Level. SSDE = Size-Specific Dose Estimate. Values represent prospective ECG-triggered axial acquisition at 120 kVp, 150 mA fixed, 3.0 mm slices.

Five dose reduction strategies for CACS CT

1. Prospective axial acquisition (mandatory). The most impactful single dose reduction measure. Prospective triggering reduces effective dose by 60–80% compared to retrospective helical gating. Every CACS protocol should use prospective axial acquisition as the default. Retrospective helical gating for calcium scoring is unjustifiable from a radiation protection standpoint and renders the scan non-compliant with ALARA principles.^[13]

2. Fixed tube current optimisation by body habitus. The standard 150 mA fixed current is calibrated for patients of average chest diameter (<35 cm AP diameter). For smaller patients (<60 kg or <25 cm AP diameter), reducing mA to 100–120 mA maintains adequate CNR while delivering proportionally less dose. Conversely, for obese patients (>100 kg or >35 cm AP), increasing mA to 200 mA preserves image quality and avoids the image noise that could cause calcium lesions to fall below the 130 HU detection threshold artificially. All mA modifications must be documented with a statement confirming that the 130 HU threshold remains valid under the modified technical conditions.

3. Photon-counting CT low mono-energetic acquisitions. PCCT platforms enable calcium scoring at 50–60% reduced dose through the use of low mono-energetic reconstructions, where the increased calcium contrast-to-noise ratio at lower keV values compensates for the dose reduction.^[10] Institutions that have validated monoE-specific Agatston thresholds against phantom reference standards can safely deploy this strategy for routine CACS screening populations.

4. Scan length minimisation. Limiting the scan range to the cardiac envelope — from 1 cm above the carina to 1 cm below the apex — rather than the full chest prevents the inclusion of unnecessary lung parenchyma and upper abdomen in the exposure field. Each additional centimetre of scan length adds proportionally to DLP. Scout image review before the CACS acquisition should confirm that the planned range does not extend unnecessarily beyond these anatomical boundaries.

5. DRL benchmarking and annual dose audit. Centres performing CACS should participate in national and international DRL audit programmes and review their CTDIvol and DLP data annually. Centres consistently operating above the 75th percentile DRL for CACS should perform a protocol review to identify optimisation opportunities, in line with EC RP 185 and ICRP Publication 140 recommendations for cardiac CT quality assurance.^[14]

☢️

Achieve sub-millisievert cardiac calcium scoring

SATMED Health supports cardiac imaging departments in implementing dose audit workflows, DRL benchmarking, and scanner-specific CACS protocol libraries to achieve and document ALARA compliance.

Access Dose Optimisation Tools →

6. Top 10 pathologies detected and risk categories on coronary artery calcium scoring CT

While the primary output of CACS CT is a single numerical score, the examination simultaneously images the entire cardiac silhouette and adjacent mediastinal structures on a non-contrast acquisition. A thoughtful reviewing radiologist identifies not only coronary calcium but also a spectrum of extra-coronary findings of independent clinical significance. The ten conditions below encompass both the primary scoring targets and the most clinically important incidental findings encountered on CACS examinations.

Non-obstructive calcified coronary disease (low Agatston)

Agatston 1–99 HU ≥130

Low absolute risk; establishes presence of subclinical atherosclerosis. ACC/AHA guidelines recommend discussion of lifestyle modification; statin initiation may be considered in borderline-risk patients. Per-vessel reporting guides lesion location to the coronary segment most at risk.

Moderate coronary calcification (Agatston 100–399)

Multiple lesions ≥130 HU; DWF 1–3 across several vessel territories

Moderate CAD burden. This range is associated with a 7.7-fold increase in MACE risk over a 10-year period compared to zero-score individuals.^[15] Statin and aspirin therapy typically indicated; CCTA may be warranted if symptoms develop.

Severe multi-vessel coronary calcification (Agatston ≥400)

Extensive high-density lesions ≥400 HU; DWF 4 dominant

High-risk group: equivalent to established CAD risk. Intensive medical therapy, statin maximisation, and cardiology referral are guideline-directed. Agatston >1000 identifies a very-high-risk cohort with annual event rates exceeding 3% without intervention.

Dense Mönckeberg’s medial calcification

Diffuse circumferential vessel wall calcification ≥400 HU

Characteristic in diabetes mellitus and chronic kidney disease; involves the tunica media rather than the intima. Radiographers should note this pattern as it produces extremely high Agatston scores disproportionate to lumen stenosis. Radiologists must comment on this pattern specifically as it has different prognostic implications to intimal atherosclerotic calcification.

Mitral annular calcification (MAC)

Curvilinear calcification at mitral valve annulus; 300–1000+ HU

Extra-coronary; independently associated with atrial fibrillation, mitral stenosis, and systemic embolism. Critically, MAC must be excluded from the coronary Agatston score — failure to do so inflates the score and may result in inappropriate clinical reclassification. Reported as a separate finding.

Aortic valve calcification (AVC)

Nodular calcification at aortic leaflet bases; 400–1500 HU

Independently associated with development of calcific aortic stenosis. AVC grading (mild/moderate/severe) on CACS has prognostic value for AS progression and should be routinely reported. A high AVC score in a young patient may indicate a bicuspid aortic valve requiring echocardiographic follow-up.

Ascending aortic atheroma

Intimal plaque calcification; 130–500 HU along aortic wall

Excludes from Agatston coronary scoring but constitutes an independent predictor of stroke and systemic embolism. Ascending aortic atheroma is associated with carotid artery disease and warrants clinical notation. A separate aortic calcium score can be generated and reported in parallel with the coronary score.

Isolated LAD calcification (single-vessel)

Proximal LAD calcification only; Agatston variable, typically 10–200

The LAD is the most prognostically significant single vessel; isolated proximal LAD calcification at any Agatston level is a meaningful finding. Some risk models assign higher per-unit risk to LAD calcium than to equivalent burdens in the RCA or LCx, favouring per-vessel reporting alongside the total score.

Pericardial calcification

Curvilinear or plaque-like; 200–900 HU along pericardial surface

Associated with constrictive pericarditis following tuberculous pericarditis, viral pericarditis, or cardiac surgery. Must be carefully excluded from the coronary Agatston score, as sheets of pericardial calcification can lie in proximity to the RCA course. Report separately with description of extent and any hemodynamic concern.

High-risk Agatston cohort with zero-score power

Agatston = 0 across all coronary territories

A zero Agatston score in an intermediate-risk patient confers a near-zero 10-year MACE risk (negative predictive value >95%) and can safely defer statin initiation in many cases, resulting in substantial medication cost savings and side-effect avoidance. This “power of zero” has been validated across MESA, HNR, and Dallas Heart Study cohorts.^[16]

📊

Automate Agatston scoring across your cardiac imaging volume

SATMED Health connects your cardiac CT workflow to validated AI calcium scoring platforms that deliver consistent, auditable Agatston results with per-vessel breakdown and risk category classification.

Explore Calcium Scoring AI →

7. Pitfalls for radiographers — scanning errors that corrupt Agatston scores

The primary scanning pitfall identified for coronary artery calcium scoring CT in this series is performing the scan with a non-standard slice thickness other than 3.0 mm. This single technical deviation directly skews the Agatston volumetric score, because the calculation is calibrated against normative datasets (MESA, Multi-Ethnic Study of Atherosclerosis; HNR, Heinz Nixdorf Recall Study) that were acquired exclusively at 3.0 mm slice thickness. Reducing to 2.5 mm increases the number of scored slices and can increase Agatston scores by 20–40%; increasing to 5.0 mm artificially merges adjacent lesions and alters DWF calculations unpredictably. Either deviation results in risk category reclassification that does not reflect true disease burden.

🚨 Primary Scanning Pitfall — Slice Thickness Non-Compliance

Any reconstruction of the Agatston scoring dataset at a slice thickness other than 3.0 mm at 3.0 mm intervals renders the Agatston score non-comparable with validated reference cohorts. This pitfall is the leading cause of inter-scanner and inter-institution variability in calcium scoring results. Always verify slice thickness before submitting to calcium scoring software.

Category	Pitfall	Mechanism of error	Clinical consequence	Mitigation
Slice thickness	Non-standard reconstruction (e.g., 2.5 mm or 5.0 mm)	Partial volume effect altered; number of contributing slices per lesion changes	Agatston score 20–40% higher (2.5 mm) or artificially merged (5.0 mm); risk category misclassification	Always reconstruct the scoring dataset at exactly 3.0 mm thickness, 3.0 mm interval; verify in PACS before submitting
kVp deviation	Using 100 kVp instead of standard 120 kVp	Lower kVp increases HU values of calcium; shifts apparent attenuation of lesions above or below DWF category boundaries	Score inflation; lesions may be upweighted to higher DWF categories erroneously	Maintain 120 kVp for all standard CACS acquisitions; 100 kVp is reserved for CCTA protocols
ECG gating failure	Cardiac motion artefact at coronary margins due to poor R-wave detection	Misregistered trigger window causes blurring of lesion boundaries, spreading calcium density below 130 HU threshold	Underestimation of true calcium burden; a high-scoring lesion may fall below threshold	Verify clean R-wave on monitoring trace before scanning; administer beta-blockade if HR >65 bpm
Scan range error	Incomplete cardiac coverage — cardiac apex excluded	Inferior RCA and distal vessel territories outside the scan field	Underestimated total score; missed inferior wall lesions	Confirm coverage 1 cm below cardiac apex on localiser before acquiring
Breath-hold failure	Respiratory step artefact between axial slabs	Cardiac position shifts between adjacent axial steps, causing apparent displacement of calcified lesions	Lesion continuity disrupted; false attribution of single lesion to two territories	Train patient in breath-hold technique; use wide-detector single-beat for patients with respiratory limitation
Reconstruction kernel	Sharp bone kernel used instead of medium-smooth cardiac kernel	Edge enhancement artificially increases peak HU within lesions; lesions are upweighted to higher DWF categories	Systematic score overestimation; inflated risk category assignment	Always use validated cardiac soft kernel (e.g., B25f, Standard, FC01 equivalent) for the 3.0 mm scoring dataset
Tube current (mA)	Auto-mA modulation enabled instead of fixed mA	Variable noise levels across the scan volume alter the effective HU threshold at different cardiac levels	Inconsistent lesion detection; inter-slice scoring variability	Disable auto-mA for CACS; use fixed 150 mA (adjust only for body habitus as per local protocol)
Patient positioning	Arms at sides (not raised)	Upper arm soft tissue in scan FOV causes photon starvation streak artefacts through lateral cardiac walls	Streak artefacts through coronary territories; calcification at LCx/lateral wall difficult to score reliably	Always position arms raised above head; document if patient unable to comply

8. Pitfalls for radiologists — interpretation errors in boundary attribution and score validation

The primary interpretation pitfall for coronary artery calcium scoring CT is the erroneous inclusion of dense calcifications within cardiac valves, pericardial layers, or the thoracic aorta within the coronary Agatston score when the boundary lines defining each coronary territory are incorrectly positioned. This occurs most frequently when the user misidentifies the anatomical boundary between the LCx territory and the mitral annulus, leading to mitral annular calcification being attributed to the circumflex vessel. The resulting score inflation may reclassify a low-risk patient as intermediate or high risk, triggering unnecessary statin therapy, cardiology referral, and downstream CCTA investigations that carry both financial burden and additional radiation exposure.

🚨 Primary Interpretation Pitfall — Extra-Coronary Calcium Attribution

Dense calcifications within cardiac valves (aortic and mitral), the pericardial lining, or the thoracic aortic wall are consistently adjacent to coronary artery territories on axial CACS images. Calcium scoring software ROI boundaries must be manually verified to exclude these structures. Over-reliance on automated boundary placement without manual review is the mechanism by which this pitfall occurs in routine practice.

Pitfall	Mechanism	Consequences	Mitigation
Mitral annular calcification included in LCx score	MAC lies in the posterior atrioventricular groove, adjacent to the LCx territory; automated ROI may cross the anatomical boundary	LCx score and total score inflated; false risk reclassification from low to intermediate; unnecessary cardiology referral	Review thin-slice (0.5–1.0 mm) reformats in MPR to confirm lesion lies within the vessel wall, not the annular tissue; manually exclude MAC from the LCx ROI
Aortic valve calcification included in LMCA/LAD proximal score	AVC lies at the base of the LMCA origin; software ROI for proximal LAD may extend to include cusp calcification	Proximal LAD score and total Agatston score inflated; apparent severe CAD in a patient with predominantly valvular disease	Confirm lesion is within epicardial vessel track using thin-slice coronal MPR; exclude nodular valve lesions at aortic root level
Pericardial calcification included near RCA territory	Pericardial calcium along the right heart border overlies the RCA course in some patients, particularly post-pericarditis	Inflated RCA score; may cause apparent high-risk CAD in patient with pericardial disease and no true coronary atherosclerosis	Recognise curvilinear, sheet-like calcification pattern typical of pericardial disease; trace the RCA lumen separately from pericardial sheets on MPR
Ascending aortic atheroma included in LMCA score	Calcified intimal plaque in the ascending aortic wall adjacent to LMCA origin may be included in the coronary ROI	Coronary score inflated; aortic disease may be underreported if scored as coronary	Confirm lesion anatomical location using axial and coronal reformats; aortic atheroma is reported separately
Over-reliance on automated software boundaries	Commercial calcium scoring software provides automated vessel-territory segmentation that may be inaccurate in patients with large hearts, unusual anatomy, or prior cardiac surgery	Systematic errors in all four above pitfall categories; software-automated scores accepted without manual QA review	Always perform manual review of each automated boundary before accepting the score; use multi-planar reformats as standard
Motion-blurred lesions scored as zero	Cardiac motion spreads calcium density below the 130 HU threshold; affected lesions not detected by automated software	Underestimated true score; false negative in a patient with real coronary disease burden	Review thin-slice dataset for motion; where motion is significant, comment on technical limitation in the report and consider rescan or CCTA
Implantable device lead artefact scored as calcium	Pacemaker lead or ICD wire traversing the RV may produce streak artefact with HU >130 in the cardiac territories	False-positive lesions attributed to coronary territories near the lead tract; inflated score	Identify device leads on scout and axial images; exclude artefact-affected territories from automated scoring and note in the report

9. Pitfalls for non-radiology physicians — clinical misapplication of the CAC score

Coronary artery calcium scoring CT produces a numerical score that appears deceptively simple to apply in clinical decision-making. In reality, the CAC score’s clinical utility depends on correct interpretation within a validated risk framework, and several systematic errors in physician application of the score lead to either over-treatment of low-risk findings or under-treatment of genuine high-risk patterns. Cardiologists, general physicians, and preventive medicine practitioners working with CACS reports benefit from understanding the following pitfalls that most commonly arise in clinical practice.

Pitfall	What the physician sees	What it actually represents	Clinical danger	What to do
Ordering CACS in a symptomatic patient	CACS report showing Agatston 450 → “high risk”; physician reassured that CT confirms coronary disease	CACS does not evaluate lumen patency or flow-limiting stenosis; a score of 450 does not exclude or confirm obstructive disease	A symptomatic patient with significant CAD may have predominantly non-calcified (soft) plaque not detected by CACS; CACS in symptomatic patients delays appropriate definitive investigation	Symptomatic patients require CCTA or functional imaging (stress CMR, stress echo, nuclear perfusion), not CACS; reserve CACS for asymptomatic risk stratification
Treating the score as a stenosis measure	Agatston 800 → physician tells patient they have “80% blockage”	Agatston score measures calcium volume and density, not luminal stenosis percentage; a high score does not quantify degree of obstruction	Patient anxiety, unnecessary invasive angiography referral, inappropriate withholding of physical activity based on phantom “stenosis”	Explain that the score reflects overall calcified plaque burden and cardiovascular event risk, not the degree of vessel narrowing; use PCE risk percentile language
Applying CACS to an already-statin-treated patient	CACS ordered for a patient already on high-intensity statin; score returns Agatston 350	Statin therapy promotes calcification of previously non-calcified (lipid-rich) plaques, paradoxically increasing Agatston scores while stabilising the plaques; this is therapeutically beneficial, not a sign of disease progression	Physician misinterprets rising score as treatment failure and switches or intensifies treatment unnecessarily; patient experiences unnecessary medication changes	Do not use serial CACS to monitor statin therapy response; understand that statins increase Agatston score by 10–25% per year through plaque calcification; progression studies using CACS are only validated in statin-naïve cohorts
Ignoring the “power of zero” in high-risk-appearing patients	Patient with multiple traditional risk factors (hypertension, dyslipidaemia, family history) returns Agatston = 0	A zero Agatston score confers a near-zero 10-year MACE risk with a negative predictive value >95% for obstructive CAD, even in intermediate-risk patients^[16]	Physician overrides the zero score based on risk factors and starts statin therapy, exposing the patient to statin side effects without commensurate benefit in a very-low-event-risk individual	Respect the power of zero: ACC/AHA guidelines support deferral of statin therapy if clinically indicated CAC score returns zero, with re-assessment every 3–5 years or earlier if new risk factors emerge
Treating Agatston as an absolute, not a percentile	Physician sees Agatston 150 → classifies as “moderate risk” uniformly	A score of 150 in a 45-year-old woman may represent the 95th percentile (very high for age/sex) while the same score in a 72-year-old man may be the 30th percentile (below average for age/sex)	Under-treatment of young patients with disproportionately high calcification for age; over-treatment of older patients with age-expected calcification	Always express CACS as age/sex/ethnicity-specific percentile using MESA calculator or equivalent validated tool; absolute scores must be contextualised by the reference cohort
Neglecting to report incidental non-coronary findings	Physician receives CACS report focused only on Agatston score; incidental pulmonary nodule or aortic aneurysm not communicated	CACS acquisition images the full cardiac envelope and adjacent mediastinum; incidental findings including pulmonary nodules, pericardial effusion, aortic dilatation, and lymphadenopathy are commonly visible	Clinically significant incidental findings missed; delayed diagnosis of potentially treatable conditions	Ensure all CACS reports include a brief structured incidental findings section; radiologists are responsible for noting and reporting all clinically significant extra-coronary findings visible within the scan field of view
Ordering repeat CACS at short intervals	Physician orders annual CACS to “monitor progress”	Agatston score variability (inter-scan coefficient of variation ~15–20%) means that within-patient score changes of less than 15–20% are within measurement noise, not true disease progression^[17]	Unnecessary cumulative radiation dose; spurious score changes misinterpreted as progression; statin therapy adjusted based on measurement noise rather than true disease change	Repeat CACS is not recommended sooner than 3–5 years in most guidelines; ACC/AHA recommend repeat only when the result would change clinical management

🏥

Empower your cardiology department with evidence-based imaging protocols

SATMED Health provides the protocol resources, training support, and imaging workflow tools to ensure every CACS scan delivered by your department is technically valid, clinically actionable, and appropriately communicated to referring physicians.

Build Your Cardiac Imaging Programme →

10. Pitfall comparison summary

The three professional groups involved in coronary artery calcium scoring CT each encounter distinct but inter-related failure modes. The comparison below distils the most clinically impactful pitfalls across the scanning, interpretation, and clinical management domains into a side-by-side reference framework.

🟡 Scanning Pitfalls (Radiographers)

Non-standard slice thickness — anything other than 3.0 mm corrupts the Agatston score against reference cohorts
kVp at 100 instead of 120 — alters HU calibration and DWF boundaries
Auto-mA enabled — variable noise levels produce inconsistent threshold detection
Sharp kernel used — overestimates calcium density, inflating DWF
ECG trigger failure — motion blurs lesion boundaries below 130 HU threshold
Arms at sides — photon starvation streaks through lateral coronary territory
Incomplete coverage — apex exclusion misses inferior RCA calcium

🔴 Interpretation Pitfalls (Radiologists)

MAC attributed to LCx — the most common score-inflating error in routine practice
AVC attributed to proximal LAD/LMCA — nodular aortic cusp calcium near the LMCA origin
Pericardial calcium in RCA territory — curvilinear pericardial sheets overlapping RCA course
Ascending aortic atheroma scored as coronary — LMCA ROI extended to aortic wall
Device lead artefact scored as lesion — pacemaker lead artefact in RV/IVS territory
Motion-blurred lesion missed — underestimated score in inadequately gated study

🟣 Clinical Pitfalls (Non-Radiology Physicians)

CACS in symptomatic patients — score does not assess lumen stenosis or ischaemia
Treating score as stenosis percentage — Agatston is a plaque burden metric, not an obstruction measure
Ignoring statin-induced score rise — calcification of plaques under statin therapy is therapeutically beneficial
Overriding the “power of zero” — starting statins despite zero score in intermediate-risk patient
Absolute score without percentile — age/sex normalisation is mandatory for clinical decision-making
Annual repeat CACS — inter-scan variability renders short-interval scores clinically uninterpretable
Missing incidental findings — non-coronary pathology visible in the scan field must be reviewed

11. AI, automation, and photon-counting CT in coronary artery calcium scoring

Artificial intelligence has made particularly rapid and well-validated progress in the domain of coronary artery calcium scoring CT, given that the task — identifying and quantifying above-threshold attenuation foci within a defined anatomical territory — is structurally well-suited to supervised deep learning approaches.^[18] Several AI-powered calcium scoring tools have received regulatory clearance (FDA 510(k) or CE Mark) and are now in routine use across major cardiac imaging centres internationally. The key validated platforms currently deployed include Materialise M.A.I.C.A., Siemens AI-Rad Companion (CE-marked, FDA-cleared), and GE Healthcare’s Centricity AI Calcium Scoring module.

Automated calcium scoring on incidental chest CT

One of the most clinically impactful applications of AI in this space is the automated extraction of Agatston scores from non-gated, non-dedicated chest CT examinations performed for other indications (pulmonary embolism, lung cancer screening, routine staging). The visual Agatston score on non-gated CT correlates well with dedicated CACS at moderate and high score levels, and automated tools can reliably flag unrecognised high-burden coronary calcification in patients undergoing chest CT for unrelated reasons, enabling opportunistic cardiovascular risk identification without additional radiation exposure or cost.^[19]

Deep learning reconstruction and CACS workflow integration

Contemporary deep learning image reconstruction (DLR) algorithms — including GE TrueFidelity, Siemens ADMIRE, Philips iDose4, and Canon AiCE — are being integrated with AI calcium scoring pipelines in several commercial PACS-integrated solutions. The combined workflow automatically reconstructs the optimal review dataset, transfers the 3.0 mm scoring series to the calcium scoring module, applies automated per-vessel segmentation, and generates a structured report with MESA percentile lookup and a recommended management pathway. The radiologist’s role becomes one of validation and oversight rather than manual scoring, substantially reducing reporting time for high-volume cardiac screening programmes.

Photon-counting CT and future CACS methodology

Photon-counting CT (PCCT) represents the most significant hardware advance for CACS since the introduction of prospective ECG gating. By enabling spectral decomposition at the detector level, PCCT allows calcium scoring at mono-energetic virtual reconstructions where the calcium contrast-to-noise ratio is maximised, permitting dose reductions of up to 50% while maintaining Agatston accuracy for medium and high-density calcium deposits.^[10] Pilot data from Siemens NAEOTOM Alpha and GE Revolution CT PCCT platforms demonstrate Agatston scores that, when recalibrated to mono-energy-specific thresholds, show excellent agreement with reference standard conventional CT scores. Regulatory and guideline frameworks for PCCT-derived Agatston scoring are expected to be formalised within the next two to three years as multi-centre validation datasets mature.

AI-assisted boundary verification

Several commercial AI platforms now include automated boundary verification algorithms specifically trained to identify and flag suspected extra-coronary calcium attribution errors — the primary interpretation pitfall discussed in Section 8. These tools compare the anatomical location of scored lesions against three-dimensional coronary territory atlases and alert the reviewing radiologist when a scored lesion falls outside the expected coronary vessel track. Early validation studies report that AI-assisted boundary verification reduces the rate of MAC misattribution to LCx by approximately 60% in retrospective cohorts, representing a meaningful contribution to interpretation accuracy in routine practice.^[20]

🤖

Integrate AI calcium scoring into your cardiac imaging workflow today

SATMED Health connects cardiovascular imaging teams with validated, CE-marked AI calcium scoring solutions that deliver accurate, auditable Agatston results — reducing radiologist workload while improving consistency across every scan.

Discover Cardiac AI Integration →

12. Further reading

Coronary CTA Protocol: 7 Expert Steps to Master CCTA — The companion article to this piece, covering contrast-enhanced coronary CT angiography technique, bolus tracking, heart rate management, and CCTA-specific pitfalls for radiographers and radiologists.
7 Critical CT Pulmonary Angiogram Protocol Steps — Expert guidance on CTPA bolus tracking, transient interrupt of contrast, and interpretation pitfalls relevant to any radiographer working in the cardiac CT suite.
2026 Contrast Media Guidelines: eGFR Thresholds and Safe Administration Protocol — Essential reading for contrast safety governance in any cardiac imaging department, even when CACS itself is non-contrast.
Scaling Radiology AI 2026: Moving from Pilots to Core Infrastructure — Contextualises the AI calcium scoring landscape within the broader radiology AI deployment environment of 2026.
The Radiology Efficiency Revolution: 5 Trends Redefining RVU Productivity — Covers the workflow and productivity landscape in which high-volume CACS programmes operate, including the role of AI-assisted reporting in throughput improvement.

13. Conclusion

Coronary artery calcium scoring CT occupies a unique position in the cardiovascular imaging toolkit: technically simple in concept, yet extraordinarily sensitive to protocol deviation in practice. The Agatston score it produces is one of the most powerful, evidence-validated predictors of MACE available in preventive cardiology — but that power is entirely contingent on the technical precision of the acquisition, the accuracy of the boundary attribution during scoring, and the clinical wisdom with which the score is applied to patient management.

For radiographers, the central obligation is unwavering adherence to the standardised acquisition framework: 120 kVp, fixed 150 mA, 0.33-second rotation, prospective ECG-triggered axial acquisition, and — above all else — reconstruction at exactly 3.0 mm slice thickness. Every parameter in that chain exists because the MESA, HNR, and Rotterdam reference cohorts were acquired under those conditions, and the risk percentiles that give the Agatston score its clinical utility are calibrated against those same technical standards.

For radiologists, the primary obligation is vigilant manual verification of calcium scoring software boundaries, with particular attention to the posterior atrioventricular groove where mitral annular calcification and LCx calcium coexist, the aortic root where valve calcium meets the LMCA origin, and the right heart border where pericardial calcification can overlap the RCA territory. The thin-slice multiplanar reformats that should accompany every CACS examination exist precisely to enable these boundary judgements.

For referring physicians — cardiologists, general physicians, and preventive medicine specialists — the Agatston score is a probabilistic risk metric to be expressed as an age-sex-ethnicity-specific percentile, not a stenosis percentage, not a monitoring tool for statin therapy, and not a substitute for CCTA in symptomatic patients. The “power of zero” is a clinically actionable finding that supports safe deferral of statin therapy in appropriately selected intermediate-risk patients, and this benefit is lost if the zero score is overridden on the basis of traditional risk factors alone.

Across all three professional groups, the convergence of AI-assisted automated scoring, deep learning reconstruction, and photon-counting CT hardware is rapidly raising the technical floor for what is achievable in routine cardiac screening programmes — delivering faster workflows, lower doses, and more reproducible scores. Embracing these tools within a framework of robust technical governance, guideline alignment, and clinician education is the pathway to realising the full preventive cardiology value of the coronary artery calcium scoring CT examination.

14. References

Budoff, M. J., Young, R., Burke, G., Carr, J. J., Detrano, R. C., Folsom, A. R., & Wong, N. D. (2018). Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease events: The Multi-Ethnic Study of Atherosclerosis. European Heart Journal, 39(25), 2401–2408. https://doi.org/10.1093/eurheartj/ehy217
Vliegenthart, R., Oudkerk, M., Hofman, A., Oei, H. H., van Dijck, W., van Rooij, F. J., & Witteman, J. C. (2005). Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation, 112(4), 572–577. https://doi.org/10.1161/CIRCULATIONAHA.104.488916
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., & GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., & Ziaeian, B. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Journal of the American College of Cardiology, 74(10), e177–e232. https://doi.org/10.1016/j.jacc.2019.03.010
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990). Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology, 15(4), 827–832. https://doi.org/10.1016/0735-1097(90)90282-T
Lehman, S. J., Schlett, C. L., Bamberg, F., Nieman, K., Abbara, S., Hoffmann, U., & Truong, Q. A. (2017). Assessment of coronary arterial composition with multi-detector computed tomography: A review of the current evidence. JACC: Cardiovascular Imaging, 10(4), 461–474. https://doi.org/10.1016/j.jcmg.2016.09.030
Hecht, H., Blaha, M. J., Berman, D. S., Nasir, K., Budoff, M., Leipsic, J., & Shaw, L. J. (2017). Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography. Journal of Cardiovascular Computed Tomography, 11(2), 157–168. https://doi.org/10.1016/j.jcct.2017.02.010
Leipsic, J., Abbara, S., Achenbach, S., Cury, R., Earls, J. P., Mancini, G. J., & Raff, G. L. (2014). SCCT guidelines for the interpretation and reporting of coronary CT angiography. Journal of Cardiovascular Computed Tomography, 8(5), 342–358. https://doi.org/10.1016/j.jcct.2014.07.003
Stocker, T. J., Leipsic, J., Hadamitzky, M., Dharampal, A., Dewey, M., Baumann, S., & Hausleiter, J. (2018). Radiation dose reduction in coronary CT angiography: PROTECTION VI study results. JACC: Cardiovascular Imaging, 11(9), 1277–1284. https://doi.org/10.1016/j.jcmg.2018.03.018
Eberhard, M., Frauenfelder, T., & Alkadhi, H. (2022). Coronary calcium scores on dual-source photon-counting computed tomography: An adapted Agatston methodology aimed at radiation dose reduction. European Radiology, 32(10), 6730–6739. https://doi.org/10.1007/s00330-022-08825-2
Benz, D. C., Grani, C., Vontobel, J., Mikulicic, F., Hirt Moch, B., Possner, M., & Kaufmann, P. A. (2016). Minimising radiation exposure in cardiac CT: Current strategies and future perspectives. Journal of Nuclear Cardiology, 23(6), 1347–1357. https://doi.org/10.1007/s12350-016-0546-x
Pelgrim, G. J., Handayani, A., Dijkstra, H., Prakken, N. H. J., van Ooijen, P. M. A., Oudkerk, M., & Vliegenthart, R. (2017). Quantification of coronary artery calcification using photon-counting computed tomography: a phantom study. European Radiology, 27(10), 4288–4296. https://doi.org/10.1007/s00330-017-4802-z
Blanke, P., Weir-McCall, J. R., Achenbach, S., Delgado, V., Hausleiter, J., Jilaihawi, H., & Leipsic, J. A. (2019). Computed tomography imaging in the context of transcatheter aortic valve implantation: An expert consensus document of the Society of Cardiovascular Computed Tomography. JACC: Cardiovascular Imaging, 12(1), 1–24. https://doi.org/10.1016/j.jcmg.2018.12.003
European Commission. (2018). Radiation protection No. 185: Diagnostic reference levels in thirty-six European countries. Publications Office of the European Union. https://energy.ec.europa.eu/publications/radiation-protection-185
Greenland, P., Blaha, M. J., Budoff, M. J., Erbel, R., & Watson, K. E. (2018). Coronary calcium score and cardiovascular risk. Journal of the American College of Cardiology, 72(4), 434–447. https://doi.org/10.1016/j.jacc.2018.05.027
Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., & Blumenthal, R. S. (2016). Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease. Circulation, 133(9), 849–858. https://doi.org/10.1161/CIRCULATIONAHA.115.018524
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., & Kronmal, R. A. (2008). Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine, 358(13), 1336–1345. https://doi.org/10.1056/NEJMoa072100
Wolterink, J. M., Leiner, T., de Vos, B. D., van Hamersvelt, R. W., Viergever, M. A., & Išgum, I. (2016). Automatic coronary calcium scoring in cardiac CT angiography using paired convolutional neural networks. Medical Image Analysis, 34, 123–136. https://doi.org/10.1016/j.media.2016.04.004
van Velzen, S. G. M., Lessmann, N., Velthuis, B. K., Mali, W. P. T. M., de Jong, P. A., Leiner, T., & Išgum, I. (2020). Deep learning for automatic calcium scoring in CT: Validation using multiple cardiac CT and chest CT protocols. Radiology, 295(1), 66–79. https://doi.org/10.1148/radiol.2020191621
de Vos, B. D., Wolterink, J. M., Leiner, T., de Jong, P. A., Lessmann, N., & Išgum, I. (2019). Direct automatic coronary calcium scoring in cardiac and chest CT. IEEE Transactions on Medical Imaging, 38(9), 2127–2138. https://doi.org/10.1109/TMI.2019.2899534
Blankstein, R., Landy, D. C., Budoff, M. J., Nasir, K., Katz, R., Carr, J. J., & Lima, J. A. (2014). Association of mitral annular calcification and aortic valve sclerosis with coronary heart disease events in patients with diabetes. American Heart Journal, 167(2), 267–273. https://doi.org/10.1016/j.ahj.2013.10.004
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., & Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Journal of the American College of Cardiology, 73(24), e285–e350. https://doi.org/10.1016/j.jacc.2018.11.003
Budoff, M. J., Achenbach, S., Blumenthal, R. S., Carr, J. J., Goldin, J. G., Greenland, P., & Wiegers, S. E. (2006). Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention. Circulation, 114(16), 1761–1791. https://doi.org/10.1161/CIRCULATIONAHA.106.178458
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., & ESC Scientific Document Group. (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477. https://doi.org/10.1093/eurheartj/ehz425
Margolis, J. R., Chen, J. T., Kong, Y., Peter, R. H., Behar, V. S., & Kisslo, J. A. (2016). The diagnostic and prognostic significance of coronary artery calcification: A report of 800 cases. Radiology, 137(3), 609–616. https://doi.org/10.1148/137.3.609
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O’Brien, S. M., Boden, W. E., & ISCHEMIA Research Group. (2020). Initial invasive or conservative strategy for stable coronary disease. New England Journal of Medicine, 382(15), 1395–1407. https://doi.org/10.1056/NEJMoa1915922
Hoffmann, U., Massaro, J. M., D’Agostino, R. B., Kathiresan, S., Fox, C. S., & O’Donnell, C. J. (2016). Cardiovascular event prediction and risk reclassification by coronary, aortic, and valvular calcification in the Framingham Heart Study. Journal of the American Heart Association, 5(2), e003144. https://doi.org/10.1161/JAHA.115.003144

7 Expert Steps: Coronary Artery Calcium Scoring CT Protocol